RecruitingNot ApplicableNCT05477277
Adverse Outcomes and Mortality in Liver Transplant
Sponsor
Mayo Clinic
Enrollment
100 participants
Start Date
Nov 2, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying MAsS for people with cirrhosis, end stage liver disease, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTMAsS
Add MAsS to standard of care MRI scan
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05477277
Related Trials
Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery
NCT075003761 location
The Effectiveness of Squat Exercise for Improving Pre-Sarcopenia in Order Adults
NCT077267581 location
Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant.
NCT063273084 locations
The Effectiveness and Safety of Combined Research on Uremic Sarcopenia
NCT077245871 location
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
NCT074171631 location